CD109 antibody (N-Term)

Catalog No. ABIN951153

Product Details anti-CD109 Antibody

Target: CD109

Binding Specificity: AA 77-109, N-Term

Reactivity: Human, Mouse

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CD109 antibody is un-conjugated

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Specificity: This antibody reacts to CD109.

Cross-Reactivity (Details): Species reactivity (tested):Human and Mouse.

Purification: Affinity chromatography on Protein A

Immunogen: KLH conjugated synthetic peptide between 77-109 amino acids from the N-terminal region of human CD109

Isotype: Ig Fraction

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS, 0.09 % (W/V) sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Target Details for CD109

Target: CD109

Alternative Name: CD109 / CPAMD7 (CD109 Products)

Synonyms: CPAMD7 antibody, RP11-525G3.1 antibody, CD109 antibody, 9930012E15Rik antibody, AI480638 antibody, GARP antibody, CD109 molecule antibody, CD109 antigen antibody, CD109 antibody, Cd109 antibody, cd109 antibody

Background: CD109 is a member of the alpha2-macroglobulin/complement superfamily. The encoded GPI-linked glycoprotein is found on the cell surface of platelets, activated T-cells, and endothelial cells. The protein binds to and negatively regulates signaling of transforming growth factor beta (TGF-beta).Synonyms: 150 KDa TGF-beta-1-binding protein, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7, Platelet-specific Gov antigen, p180, r150

Molecular Weight: 161689 Da

Gene ID: 135228

NCBI Accession: NP_001153059

Pathways: Activated T Cell Proliferation